Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.
Balapal S BasavarajappaShivakumar SubbannaPublished in: Epigenomics (2024)
Recent genomics and epigenetic advances have empowered the exploration of DNA/RNA methylation and histone modifications crucial for gene expression in response to stress, aging and disease. Interest in understanding neuronal plasticity's epigenetic mechanisms, influencing brain rewiring amid development, aging and neurodegenerative disorders, continues to grow. Histone acetylation dysregulation, a commonality in diverse brain disorders, has become a therapeutic focus. Histone acetyltransferases and histone deacetylases have emerged as promising targets for neurodegenerative disorder treatment. This review delves into histone acetylation regulation, potential therapies and future perspectives for disorders like Alzheimer's, Parkinson's and Huntington's. Exploring genetic-environmental interplay through models and studies reveals molecular changes, behavioral insights and early intervention possibilities targeting the epigenome in at-risk individuals.
Keyphrases
- dna methylation
- gene expression
- genome wide
- copy number
- randomized controlled trial
- white matter
- resting state
- multiple sclerosis
- cognitive decline
- risk assessment
- cerebral ischemia
- functional connectivity
- subarachnoid hemorrhage
- cell free
- mild cognitive impairment
- cancer therapy
- circulating tumor cells
- replacement therapy
- case control